The limitation of PET imaging for biological adaptive-IMRT assessed in animal models

Radiotherapy and Oncology

Volumn 91, Issue 1, 2009, Pages 101-106

  Christian, Nicolas ^a   Lee, John A ^a   Bol, Anne ^a   De Bast, Marc ^a   Jordan, B ^a   Grégoire, Vincent ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Animal PET; Autoradiography; FDG; Image guided radiotherapy; Molecular imaging; Mouse tumor

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; IMAGE ANALYSIS; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; WHOLE BODY PET;

ANIMALS; AUTORADIOGRAPHY; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; FIBROSARCOMA; FLUORODEOXYGLUCOSE F18; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; NEOPLASM TRANSPLANTATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 62749154562     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.11.014     Document Type: Article

References (23)

1. Hoogsteen I.J., Marres H.A., Bussink J., van der Kogel A.J., and Kaanders J.H. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review. Head Neck 29 (2007) 591-604
2. De Neve W., and Duthoy W. Intensity-modulated radiation therapy for head and neck cancer. Expert Rev Anticancer Ther 4 (2004) 425-434
3. Lauve A., Morris M., Schmidt-Ullrich R., Wu Q., Mohan R., Abayomi O., et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II. Clinical results. Int J Radiat Oncol Biol Phys 60 (2004) 374-387
4. 18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism. Eur J Nucl Med Mol Imaging 35 (2008) 1282-1289
5. 18F]fluorothymidine. Semin Nucl Med 37 (2007) 429-439
6. Chao K.S., Bosch W.R., Mutic S., Lewis J.S., Dehdashti F., Mintun M.A., et al. A novel approach to overcome hypoxic tumor resistance. Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
7. Douglas J.G., Stelzer K.J., Mankoff D.A., Tralins K.S., Krohn K.A., Muzi M., et al. [F-18]-Fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 64 (2006) 886-891
8. Grosu A.L., Souvatzoglou M., Roper B., Dobritz M., Wiedenmann N., Jacob V., et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 541-551
9. Lee N.Y., Mechalakos J.G., Nehmeh S., Lin Z., Squire O.D., Cai S., et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 70 (2007) 2-13
10. Bentzen S.M. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol 6 (2005) 112-127
11. 18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol 79 (2006) 249-258
12. Soret M., Bacharach S.L., and Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med 48 (2007) 932-945
13. Milas L., Hunter N., and MasonK Withers.H.R. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res 34 (1974) 61-71
14. Christian N., Lee J.A., Bol A., De Bast M., Gallez B., and Grégoire V. Immobilization device for in vivo and in vitro multimodality image registration of rodent tumors. Radiother Oncol 87 (2008) 147-151
15. Huisman M.C., Reder S., Weber A.W., Ziegler S.I., and Schwaiger M. Performance evaluation of the Philips MOSAIC small animal PET scanner. Eur J Nucl Med Mol Imaging 34 (2007) 532-540
16. Dice L.R. Measures of the amount of ecologic association between species. Ecology 26 (1945) 297-302
17. Gregory R., Partridge M., and Flower M.A. Performance evaluation of the Philips "Gemini" PET/CT system. IEEE Trans Nuclear Sci 53 (2006) 93-101
18. Teräs M., Tolvanen T., Johansson J.J., Williams J.J., and Knuuti J. Performance of the new generation of whole-body PET/CT scanners: discovery STE and Discovery VCT. Eur J Nucl Med Mol Imaging 34 (2007) 1683-1692
19. Geworski L., Knoop B.O., de Cabrejas M.L., Knapp W.H., and Munz D.L. Recovery correction for quantitation in emission tomography: a feasibility study. Eur J Nucl Med 27 (2000) 161-169
20. Reader A.J. The promise of new PET image reconstruction. Phys Med 24 (2008) 49-56
21. Daisne J.F., Duprez T., Weynand B., Lonneux M., Hamoir M., Reychler H., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG-PET and validation with surgical specimen. Radiology 233 (2004) 93-100
22. Geets X., Tomsej M., Lee J.A., Duprez T., Coche E., Cosnard G., et al. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol 85 (2007) 105-115
23. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70